Carregant...
Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors
BACKGROUND: Blocking the mechanistic target of rapamycin complex-1 (mTORC1) with chemical inhibitors such as rapamycin has shown limited clinical efficacy in cancer. The tumor microenvironment is characterized by an acidic pH which interferes with cancer therapies. The consequences of acidity on the...
Guardat en:
| Publicat a: | Mol Cancer |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5139076/ https://ncbi.nlm.nih.gov/pubmed/27919264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-016-0562-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|